Putnam Investments’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Putnam Investments’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-43,435	Closed	-$5.92M	–	901
2020 Q3	$5.92M	Sell	43,435 -55	-0.1%	-$5.85K	0.01%	451
2020 Q2	$4.2M	Buy	+43,490	New	+$3.63M	0.01%	505
2018 Q1	–	Sell	-85,000	Closed	-$3.58M	–	1214
2017 Q4	$3.58M	Buy	+85,000	New	+$3.28M	0.01%	601

Putnam Investments's MYOK Position: Q4 2020 in Review

Putnam Investments sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 43,435 shares — an estimated $5.92M sold.

Putnam Investments first reported a position in MYOK in Q4 2017 and held it in 3 quarters. The position peaked at $5.92M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Putnam Investments reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Putnam Investments sold 43,435 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $5.92M.
Putnam Investments first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
Putnam Investments's MyoKardia, Inc. Common Stock position peaked at $5.92M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Putnam Investments's 13F filing for Q4 2020, filed 16 Feb 2021.